Oregon Public Employees Retirement Fund’s NovoCure NVCR Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,474	Closed	-$111K	–	1702
2021 Q4	$111K	Sell	1,474 -13,900	-90%	-$1.4M	﹤0.01%	1565
2021 Q3	$1.79M	Sell	15,374 -126	-0.8%	-$19.1K	0.02%	659
2021 Q2	$3.44M	Buy	15,500 +2,895	+23%	+$563K	0.04%	402
2021 Q1	$1.67M	Buy	12,605 +1,505	+14%	+$238K	0.02%	682
2020 Q4	$1.92M	Buy	+11,100	New	+$1.52M	0.03%	554

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oregon Public Employees Retirement Fund's NVCR Position: Q1 2022 in Review

Oregon Public Employees Retirement Fund sold out of NovoCure (NVCR) in Q1 2022, closing a stake of 1,474 shares — an estimated $111K sold.

Oregon Public Employees Retirement Fund first reported a position in NVCR in Q4 2020 and held it in 5 quarters. The position peaked at $3.44M in Q2 2021. 308 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

Oregon Public Employees Retirement Fund reported no remaining NovoCure position as of Q1 2022 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 1,474 NovoCure shares in Q1 2022, an estimated $111K.
Oregon Public Employees Retirement Fund first reported a position in NovoCure in Q4 2020 and held it in 5 quarters.
Oregon Public Employees Retirement Fund's NovoCure position peaked at $3.44M in Q2 2021.
308 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2022, filed 21 Apr 2022.